• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-600
Device Problem Imprecision (1307)
Patient Problems Fatigue (1849); Hyperglycemia (1905)
Event Date 10/28/2023
Event Type  Injury  
Event Description
On october 30, 2023, senseonics was made aware of an adverse event where the user went to er for hyperglycemia and having symptoms of fatigue on 24 october 2023.
 
Manufacturer Narrative
This mdr is a result of retrospective review of complaints.The manufacturer is currently performing an investigation and will provide the results with the supplemental report.
 
Manufacturer Narrative
Customer reported a high glucose event that led to an er visit on (b)(6) 2023 for elevated bg value of 283mg/dl.The customer began experiencing fatigue symptoms on (b)(6) 2023.On that same day, the user entered two calibration entries, one at 3:10 pm (260 mg/dl) and another at 6:43 pm (254 mg/dl).From (b)(6) 2023 2:54 pm through (b)(6) 2023 7:04 pm as there was no sg data available.During that time frame the sensor was frequently not connected to the transmitter resulting in multiple "sensor not detected" alerts, and the user was in the initialization phase due to calibration past due.Upon reviewing the alert history, it was observed that several high glucose alerts were received on 24th, 29th and 30th of october.The user sought medical attention by visiting the emergency room on the 28th october.They subsequently had their metformin dose increased to 100 mg daily on (b)(6) 2023.The primary care physician also initiated ozempic treatment on (b)(6) 2023.The user has been unresponsive and is currently not using the system.No further investigation was possible for this complaint.H3.Device evaluated by manufacturer?no,other h6.Investigation findings updated to 114 h6.Investigation conclusions updated to 4315.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18252952
MDR Text Key329550814
Report Number3009862700-2023-00310
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/01/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date01/23/2024
Device Model Number102208-600
Device Lot Number135516
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received10/30/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/23/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age40 YR
Patient SexFemale
-
-